3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
26
Small Cell Lung Carcinoma
22
Neuroblastoma
12
Fallopian Tube Neoplasms
12
Uterine Cervical Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Lung Neoplasms
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
4
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Brain Neoplasms
3
Sarcoma
2
Recurrence
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Small Cell
2
Carcinoma, Neuroendocrine
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Retinoblastoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Interventions
fludarabine phosphate
15
Cyclophosphamide
13
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Tacrolimus
10
Etoposide
10
Rituximab
8
Mycophenolic Acid
8
Methotrexate
6
Melphalan
6
Cyclosporine
6
Busulfan
6
Antilymphocyte Serum
6
Vorinostat
4
Sirolimus
4
Prednisone
4
Lenalidomide
4
Immunohistochemistry
4
Gene Expression Profiling
4
Carboplatin
4
Vincristine
3
Microarray Analysis
3
Gemcitabine
3
Everolimus
3
Doxorubicin
3
Dexamethasone
3
Brentuximab Vedotin
3
Alemtuzumab
3
10-propargyl-10-deazaaminopterin
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoblastic Lymphadenopathy
×
Topotecan
×
Clear all
No trials found.